TMC secures UK MAH for rare disease product in the United Kingdom
TMC, a global clinical research organisation (CRO) dedicated to [...]
Understanding the role of a marketing authorisation holder in the regulatory submission process
In clinical research and drug development, regulatory submissions are [...]
TMC appointed UK marketing authorisation holder to drive rapid commercialisation of rare disease drug
TMC, a global clinical research organisation (CRO) dedicated to [...]
CDER establishes new ‘Center for real-World Evidence Innovation’
The FDA’s Center for Drug Evaluation and Research (CDER) [...]